26 Jan 2022 Edison Edison Open House Healthcare 2022
28 Oct 2021 Ticker News Cognitive Impairment: A drug for the treatment of Alzheimer’s
09 Aug 2021 ShareCafe ShareCafe Small Cap “Hidden Gems” Webinar presentation
15 Jun 2021 Switzer Financial Group Dr Steven Gourlay from Actinogen | The CEO Masterclass
07 May 2021 180 Markets 18 Minutes with Actinogen MD Steven Gourlay
21 Apr 2021 Daily Motion / Australian Business News Actinogen undervalued by the market
21 Apr 2021 Ausbiz Actinogen undervalued by the market
01 Dec 2020 Switzer TV Actinogen Medical CEO Dr Bill Ketelbey speaks at the Switzer Small and Micro Cap Virtual Investor Day 2020
09 Nov 2020 Finance News Network Actinogen Medical (ASX:ACW) tackling Alzheimer’s by inhibiting excess cortisol production in the brain
03 Nov 2020 The Market Herald Actinogen Medical (ASX:ACW) to test Fragile X syndrome treatment in Melbourne clinical trial WATCH FROM 4:50 to 13:33
02 Nov 2020 Boardroom Media ASX: ACW World first medical trial Fragile X Syndrome
29 Oct 2020 Monsoon Communications Monsoon Morning Twilight Investor Briefing webinar video (28 Oct 2020) – watch from 17:50 Dr Bill Ketelbey provided a clinical development update
19 Oct 2020 Actinogen Actinogen Medical Conference Call 19 Oct 2020: Audio only
22 Nov 2019 Edison TV Executive Interview – Actinogen Medical CEO, Dr Bill Ketelbey, provides an update on recent developments, R&D progress and expected newsflow
08 Nov 2019 Stockhead TV 90 Seconds with… Actinogen Medical. Dr Bill Ketelbey tells us about his AusBiotech Invest presentation and upcoming newsflow
30 Oct 2019 Boardroom Media ASX:ACW Market update October 2019: Will Canty speaks to Bill Ketelbey at 10th Annual Australian Microcap Investment Conference
22 Oct 2019 Morgans Financial Limited Under The Microscope Podcast: Morgans Senior Analyst Scott Power interview with Dr Bill Ketelbey explaining recent clinical trial results and the path forward for Xanamem
01 Oct 2019 Actinogen Conference Call Audio: 1 Oct 2019 Cognitive improvement demonstrated with Xanamem
14 Apr 2019 The Today Show Alzheimer’s breakthrough: New drug targets cortisol, the stress hormone in the brain
08 Apr 2019 7 News Alzheimer’s breakthrough could be just a pill away after medical trial in Perth
08 Apr 2019 The West Australian Perth trial gives hope for Alzheimer’s breakthrough
08 Apr 2019 Perth Now Perth trial gives hope for Alzheimer’s breakthrough
28 Mar 2019 Morgans Financial Limited Under the Microscope Video: Morgans Senior Analyst Scott Power, interviewed Dr Bill Ketelbey, CEO & Managing Director of Actinogen Medical
28 Mar 2019 Morgans Financial Limited Under the Microscope Podcast: Morgans Senior Analyst Scott Power, interviewed Dr Bill Ketelbey, CEO & Managing Director of Actinogen Medical
20 Mar 2019 Edison TV Executive Interview with Dr Bill Ketelbey, CEO, Actinogen Medical
28 Nov 2018 Actinogen Actinogen Medical XanADu, Xanamem & Cortisol: Oct 2018 Barcelona
31 Oct 2018 Ch 9 News Online Cortisol-blocking drug could slow Alzheimer’s Actinogen Medical and Xanamem featured on national TV referencing our XanADu trial in Alzheimer’s disease. The trial has recruited the last patient and is on track to report out results in less than 8 months!
31 Oct 2018 Ch 9 News Stress could lead to dementia Actinogen Medical and Xanamem featured on national TV referencing our XanADu trial in Alzheimer’s disease. The trial has recruited the last patient and is on track to report out results in less than 8 months!
25 Sep 2018 Finance News Network Actinogen Medical (ASX:ACW) Phase II Alzheimer’s trials
07 Sep 2018 Talking Business Ep 30: Podcast interview with Leon Gettler & Dr Bill Ketelbey (Play from 1:00 to 16.50)
28 Jun 2018 CommSec Executive Series Dr Bill Ketelbey speaks with Tom Piotrowski about the company’s Ph II clinical trial for the treatment of Alzheimer’s disease
24 May 2018 SkyNews.com.au Business | Tech.Biz | VIEW FROM 16:49 Actinogen Medical announces $15 million capital raise
29 Nov 2017 Actinogen Actinogen Medical & KaRa Minds: Leading Alzheimer’s Researchers Address to Shareholders Dr Bill Ketelbey speaks with Prof Ralph Martins and Associate Prof Kathryn Goozee from KaRa Minds following the Actinogen Medical AGM
28 Nov 2017 Ted.com Elizabeth Blackburn at TED2017: The science of cells that never get old
24 Oct 2017 Hot Copper / BIG Business News & Finance Australian Microcap Investment Conference: Interview with Dr Bill Ketelbey
09 Jul 2017 Channel 9 News National Breakthrough Alzheimer’s medication could ‘make a difference’ in just three months

Back
to top